For FY2017, President Obama proposed $152.333 billion for R&D, an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion. Under President Obama's FY2017 budget request, seven federal agencies would have received more than 95% of total federal R&D funding: the Department of Defense (DOD), 49.5%; Department of Health and Human Services (HHS) (primarily the National Institutes of Health [NIH]), 21.3%; Department of Energy (DOE), 8.6%; National Aeronautics and Space Administration (NASA), 8.4%; National Science Foundation (NSF), 4.3%; Department of Agriculture (USDA), 2.0%; and Department of Commerce (DOC), 1.5%. The largest agency R&D increases in President Obama's FY2017 request (as measured in dollars), compared with FY2016, were for DOE, up $2.755 billion (19.1%); DOD, up $1.953 billion (2.8%); HHS, up $772 million (2.4%); NSF, up $412 million (6.7%); and USDA, up $249 million (9.3%). In President Obama's FY2017 budget request, the Department of Health and Human Services, primarily NIH, accounted for nearly half (47.3%) of all federal funding for basic research. Multiagency R&D Initiatives

President Obama's FY2017 budget request supported several multiagency R&D initiatives. Global Change Research Program14

The U.S. Two R&D-focused components of the AMP are the National Robotics Initiative (NRI) and the National Network for Manufacturing Innovation (NNMI). As of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2017. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them. 114-254 ). Division A, Further Continuing Appropriations Act, 2017, generally provides continuing appropriations for most federal agencies at 99.8% of FY2016 funding through April 28, 2017, subject to other provisions in the act, pending final action on the remaining 11 regular appropriations acts for FY2017. Division B, Security Assistance Appropriations Act, 2017, includes additional funding for DOD RDT&E, designated by Congress as Overseas Contingency Operations/Global War on Terrorism funding. On September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act ( P.L. 114-223 ). This act, among other things, had provided continuing appropriations for most federal agencies through December 10, 2016, at about 99.5% of FY2016 funding. The act provides FY2017 funding for most federal agencies, except those already provided for in P.L. Where possible, R&D funding provided under this act is identified in the following sections of this report. For some agencies, however, funding for R&D is included in appropriations line items that also include non-R&D activities; therefore, it is not possible to identify precisely how much of the funding provided in appropriations laws is allocated to R&D specifically. On December 10, President Obama signed into law the Further Continuing and Security Assistance Appropriations Act, 2017 ( P.L. Precision Medicine Initiative. The Consolidated Appropriations Act, 2017 ( P.L. Research . Construction . The Networking and Information Technology Research and Development would have received $1.254 billion, an increase of $59 million (4.9%). In May 2017, Congress enacted P.L. 114-223 ). 115-31 , providing FY2017 funding for the Department of the Interior and other departments and agencies. 115-31 , is intended for R&D activities, due to the inclusion of R&D funding in accounts that also include non-R&D funding.
President Obama's budget request for FY2017 included $152.333 billion for research and development (R&D), an increase of $6.195 billion (4.2%) over the estimated FY2016 enacted R&D funding level of $146.138 billion.
Funding for R&D is concentrated in a few departments and agencies. Under President Obama's FY2017 budget request, seven federal agencies would have received 95.6% of total federal R&D funding, with the Department of Defense (47.8%) and the Department of Health and Human Services (21.5%) accounting for nearly 70% of all federal R&D funding.
In dollars, the largest increases in agency R&D funding in President Obama's request would have gone to the Department of Energy (up $2.755 billion, 19.1%), the Department of Defense (up $1.953 billion, 2.8%), and the Department of Health and Human Services (up $772 million, 2.4%).
President Obama's FY2017 request sought to continue support for a number of multiagency R&D initiatives: the National Nanotechnology Initiative, Networking and Information Technology Research and Development program, U.S. Global Change Research Program, Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative, Precision Medicine Initiative, Cancer Moonshot, Materials Genome Initiative, National Robotics Initiative, and National Network for Manufacturing Innovation.
As of September 28, 2016, Congress had not completed action on any of the 12 regular appropriations bills for FY2017. The House Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the House had passed three of them. The Senate Committee on Appropriations had reported all nine of the regular appropriations bills that provide R&D funding, and the Senate had passed three of them.
On September 29, 2016, President Obama signed into law the Continuing Appropriations and Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2017, and Zika Response and Preparedness Act (P.L. 114-223). This act, among other things, provided full-year funding for military construction and the Department of Veteran's Affairs, as well as continuing appropriations for most federal agencies through December 9, 2016, at about 99.5% of FY2016 funding. On December 10, President Obama signed into law the Further Continuing and Security Assistance Appropriations Act, 2017 (P.L. 114-254). Division A, Further Continuing Appropriations Act, 2017, generally provides continuing appropriations for most federal agencies at 99.8% of FY2016 funding through April 28, 2017, subject to other provisions in the act, pending final action on the remaining 11 regular appropriations acts for FY2017. Division B, Security Assistance Appropriations Act, 2017, included additional funding for DOD RDT&E, designated by Congress as Overseas Contingency Operations/Global War on Terrorism funding.
In May 2017, Congress enacted the Consolidated Appropriations Act, 2017 (P.L. 115-31). The act provides FY2017 funding for most federal agencies, except those already provided for in P.L. 114-223. Where possible, R&D funding provided under this act is identified in the following sections of this report. For some agencies, however, funding for R&D is included in appropriations line items that also include non-R&D activities; therefore, it is not possible to identify precisely how much of the funding provided in appropriations laws is allocated to R&D specifically. No further updates of this report are anticipated.
Completion of the annual appropriations process after the start of the fiscal year and the use of continuing resolutions can affect agencies' execution of their R&D budgets, including the delay or cancellation of planned R&D activities and acquisition of R&D-related equipment.